Put Options

18 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $3.62 Million - $4.55 Million
-5,000 Reduced 7.15%
64,900 $58.8 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $26.8 Million - $35.9 Million
45,300 Added 184.15%
69,900 $54.4 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $2.05 Million - $2.41 Million
3,900 Added 18.84%
24,600 $14.3 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $5.58 Million - $7.46 Million
15,900 Added 331.25%
20,700 $9.71 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $962,953 - $1.13 Million
3,100 Added 182.35%
4,800 $1.65 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $289,395 - $337,203
-900 Reduced 34.62%
1,700 $621,000
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $148,240 - $168,935
-500 Reduced 16.13%
2,600 $841,000
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $10.6 Million - $13.1 Million
-45,000 Reduced 93.56%
3,100 $888,000
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $157,395 - $195,328
-700 Reduced 1.43%
48,100 $13.3 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $132,960 - $163,626
600 Added 1.24%
48,800 $11.3 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $6.23 Million - $8.06 Million
34,500 Added 251.82%
48,200 $11.1 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $2.04 Million - $2.64 Million
12,400 Added 953.85%
13,700 $2.56 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $65,230 - $86,315
-500 Reduced 27.78%
1,300 $219,000
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $73,110 - $84,565
500 Added 38.46%
1,800 $266,000
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $177,345 - $213,434
1,300 New
1,300 $213,000
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $488,105 - $604,135
-4,100 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $224,532 - $278,103
2,100 Added 105.0%
4,100 $539,000
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $213,580 - $232,320
2,000 New
2,000 $224,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.